Kazakh Phenom Provisionally Banned for CERA
“], “filter”: { “nextExceptions”: “img, blockquote, div”, “nextContainsExceptions”: “img, blockquote, a.btn, a.o-button”} }”>
Don’t miss a moment of the 2024 Tour de France! Get recaps, insights, and exclusive takes with Velo’s daily newsletter.
>”,”name”:”in-content-cta”,”type”:”link”}}”>Sign up today!.
A promising rider from Kazakhstan is now on the UCI’s provisional banned list for an old-school product — CERA.
Ilkhan Dostiyev, 22, tested positive for CERA during a doping control in July. The UCI revealed the provisional ban Monday.
Dostiyev can request that the “B sample” be tested. The Kazakh could face a four-year ban and he cannot compete until his case is adjudicated.
He joined the Astana Qazaqstan development team in 2024, and posted some big results this season.
In February, he was second in the Tour du Rwanda to Joe Blackmore, the young British talent now on Israel-Premier Tech who also won the Tour de l’Avenir in August.
Dostiyev won a stage at the Orlen Nations GP in May and also won a stage and finished second in July at the U23 stage race Giro Ciclistico della Valle d’Aosta-Mont Blanc, where only highly touted Belgian rider Jarno Widar beat him on GC.
In August, he won the five-stage Turul Romaniei in Romania.
One of the more surprising aspects of the case is the presence of CERA, one of the most notorious products during the EPO era.
CERA (continuous erythropoietin receptor activator) is a variant of EPO, and is relatively easy to detect. Medically, it is used to treat anemia for patients with kidney disease.
Riders such as Riccardo Riccò, Stefan Schumacher, Danilo Di Luca, Bernhard Kohl, and Davide Rebellin were also busted for CERA in the 2000s.